BFC Planning, Inc.’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
BFC Planning, Inc.'s MIRM Position: Q3 2026 in Review
BFC Planning, Inc. held its Mirum Pharmaceuticals (MIRM) position steady in Q3 2026 at 25 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2988.
BFC Planning, Inc. first reported a position in MIRM in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.79K in Q1 2026. 231 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.
- BFC Planning, Inc. held 25 shares of Mirum Pharmaceuticals worth $2.14K as of Q3 2026.
- BFC Planning, Inc. left its Mirum Pharmaceuticals share count unchanged in Q3 2026.
- Mirum Pharmaceuticals made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q3 2026, its #2988 holding.
- BFC Planning, Inc. first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- BFC Planning, Inc.'s Mirum Pharmaceuticals position peaked at $3.79K in Q1 2026.
- 231 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.
Based on BFC Planning, Inc.'s 13F filing for Q3 2026, filed 13 Nov 2026.